Autres langues Vistin Pharma ASA

Actions

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 08/05/2024			Varia. 5j.	Varia. 1 janv.
22,7 ^NOK	0,00%		-3,40%	-2,58%

24/04	Vistin Pharma ASA publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
24/04	Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024

Vistin Pharma : Code of Conduct	03/05
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024	30/04
Vistin Pharma : Annual Report 2023	25/04
Vistin Pharma ASA: Annual Report 2023	24/04
Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Vistin Pharma ASA: First quarter 2024 financial results	24/04
Vistin Pharma ASA: Invitation to Q1 2024 conference call	16/04
Vistin Pharma ASA: Invitation to Q1 2024 conference call	16/04
Vistin Pharma ASA: Mandatory notification of trade	22/03
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)	04/03
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)	04/03
Vistin Pharma ASA (OB:VISTN) acquired 15% stake in CF Pharma Ltd. for ?1.6 million.	04/03
Vistin Pharma ASA: Key information relating to the proposed cash dividend	16/02
Vistin Pharma ASA: Key information relating to the proposed cash dividend	16/02
Vistin Pharma ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	16/02
Vistin Pharma ASA Reports Earnings Results for the Full Year Ended December 31, 2023	16/02
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results	16/02
Vistin Pharma ASA Proposes an Ordinary Dividend for the Accounting Year of 2023, Payable on or About 18 June 2024 and 19 November 2024	16/02
Vistin Pharma ASA: Invitation to Q4 2023 conference call	09/02
Vistin Pharma ASA: Invitation to Q4 2023 conference call	09/02

Aucun résultat pour cette recherche